Late mortality from pT1N0M0 breast carcinoma

Cancer

Volumn 85, Issue 10, 1999, Pages 2183-2189

  Joensuu, Heikki ^a   Pylkkänen, Liisa ^b   Toikkanen, Sakari ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Breast carcinoma; Histopathologic grading; Pathologic staging; Prognostic factors; Surgery; TNM staging system

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS;

EID: 0345711457     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990515)85:10<2183::AID-CNCR12>3.0.CO;2-K     Document Type: Article

References (18)

1. Early Breast Cancer Trialists's Collaborative Group. Systemic adjuvant treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992;339:1-15, 71-85.
2. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 1995;13:1144-51.
3. Hermanek P, Sobin LH, editors. International Union Against Cancer TNM classification of malignant tumours. 4th edition. Berlin: Springer-Verlag, 1992.
4. World Health Organization. International histologic classification of tumours. 2nd edition. Geneva: World Health Organization, 1981.
5. Joensuu H, Toikkanen S. Cured of breast cancer? J Clin Oncol 1995;13:62-9.
6. Carter CL, Allen C, Henson DE. Relationship of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63;181-7.
7. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7:355-66.
8. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with a median follow-up of 18 years. J Clin Oncol 1989;7: 1239-51.
9. Rosen PP, Groshen S. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years. Surg Clin North Am 1990;70:937-62.
10. Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blarney RW, et al. Pathological prognostic factors in breast cancer. IV: should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 1995;27: 219-26.
11. Nealon TF Jr., Nkongho A, Grossi CE, Ward R, Nealon C, Gillooley JF. Treatment of early cancer of the breast (T1N0M0 and T2N0M0) on the basis of histologic characteristics. Surgery 1981;89:279-89.
12. Bilik R, Mor C, Wolloch Y, Dintsman M. Histopathologic high risk factors influencing the prognosis of patients with early breast cancer (T1N0M0). Am J Surg 1986;151: 460-4.
13. Leitner SP, Swern AS, Weinberger D, Duncan LJ, Hutter RVP. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,bN0M0). Cancer 1995;76:2266-74.
14. Rosen PP, Groshen S, Kinne DW, Norton L. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 1993;11:2090-100.
15. Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, Soerensen FB. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. J Pathol 1995;176: 343-52.
16. Crowe JP, Gordon NH, Shenk RR, Zollinger RM, Brumberg DJ, Shuck JM. Primary tumor size. Relevance to breast cancer survival. Arch Surg 1992;127:910-6.
17. Nab HW, Hop WCJ, Crommelin MA, Kluck HM, van der Heijden LH, Coebergh JW. Changes in long term prognosis for breast cancer in a Dutch cancer registry. BMJ 1994;309: 83-6.
18. Klemi PJ, Joensuu H, Toikkanen S, Tuominen J, Räsänen O, Tyrkkö J, et al. Aggressiveness of breast cancers found with or without screening. BMJ 1992;304:467-9.